VIP

FDA APPROVAL PENDING

Extensively Studied

Cognitive

Immunity

Cognitive

VIP

Immunity

Amino acid sequence

3

Amino acids

497.6da

Molecular weight

Peptide

Type

Vasoactive Intestinal Peptide (VIP) is a 28-amino acid neuropeptide belonging to the glucagon/secretin superfamily. It is produced in many tissues including the gut, pancreas, and brain. VIP has potent vasodilatory, anti-inflammatory, and immunomodulatory effects. It binds to VPAC1 and VPAC2 receptors, triggering cAMP-mediated signaling cascades. Research shows therapeutic potential for pulmonary hypertension, diabetes, neurological disorders, and autoimmune conditions.

Top researched benefits

Overview of VIP

VIP binds to VPAC1 and VPAC2 G protein-coupled receptors, activating adenylyl cyclase and increasing intracellular cAMP and PKA activity. This triggers phosphorylation of CREB and other transcription factors. VIP causes vasodilation through NO-dependent and independent mechanisms, stimulates intestinal secretion, relaxes smooth muscle, inhibits gastric acid secretion, and has positive inotropic/chronotropic cardiac effects.

Cardiovascular

  • VIP inhalation shows striking efficacy with increased mixed venous oxygen saturation and exercise capacity.
  • Dilates peripheral blood vessels through NO-dependent mechanisms above 100 pmol doses.
  • Coronary vasodilation with positive inotropic and chronotropic effects on the heart.

Neurological

  • Promising therapeutic target for Alzheimer's, Parkinson's, and other neurological disorders.
  • Potential therapeutic target being researched for ASD.
  • Produced in suprachiasmatic nuclei; involved in circadian regulation.

Metabolic And Immune

  • Promotes insulin secretion in glucose-dependent manner via VPAC2; low hypoglycemia risk.
  • Potent anti-inflammatory effects useful in IBD and autoimmune conditions.
  • Therapeutic potential for pulmonary and systemic sarcoidosis.

Storage

Lyophilized powder: 2-8°C refrigerated; Reconstituted: use immediately (very short stability, ~2 minute half-life)

Frequency

1-2 times daily due to very short 2-minute half-life

Typical Dose

50-100 mcg per dose (up to 200 mcg in research protocols)

Cycle Duration

As prescribed for specific condition

Chemical Makeup

Key benefits

Potent vasodilation and blood pressure reduction

Strong anti-inflammatory effects

Immunomodulation (Th1-Th2 balance)

Neuroprotective effects

Bronchodilation

Cardioprotective (positive inotropic effects)

Insulin secretion enhancement (glucose-dependent)

Gut barrier and permeability regulation

Community interest

This peptide is still gaining traction in the community.

Vasoactive Intestinal Peptide | Neuropeptide

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes

VIP Molecular Information

View the scientifc details of VIP.

3

Amino Acids

VIP

His

His

Position 1

Trp

Trp

Position 2

Arg

Arg

Position 3

Amino acid sequence
HistidinePosition 1
TryptophanPosition 2
ArgininePosition 3

Molecular Weight

497.6Da

Chain Length

3Amino Acids

Type

Peptide

VIP Protocols

VIP has a very short half-life of approximately 2 minutes in blood, requiring careful dosing strategies. Subcutaneous or intravenous administration. Rapid degradation limits bioavailability; analogs like stearyl-Nle17-VIP (SNV) are 100-fold more potent.

GoalDosageFrequencyRoute
General use501 week rangeSubQ or IV
Research protocols100SubQ or IV

Reconstitution Instructions

Materials needed:

Bacteriostatic water (BAC)Insulin syringesAlcohol swabsPeptide vialSterile work surface

Steps to reconstitute

  1. Clean work area and hands thoroughly
  2. Calculate required BAC water volume
  3. Draw BAC water into syringe
  4. Inject slowly down vial side
  5. Gently swirl until dissolved (never shake)
  6. Use promptly due to short stability

VIP Cycle

The VIP Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 0-0
Rapid vasodilation and hemodynamic effects
Week 0-0
Anti-inflammatory signaling activated
Week 0-0
Cumulative effects on inflammation and immune balance
Week 0-0
Sustained benefits with regular administration

Dosing tools

VIP Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

0.3mL / 30 units

5 units

0.050 mL

1 mL

2 mL

3 mL

5 mL

Custom

Conversion: 1,000 mcg = 1 mg

Injection Results

Based on your vial and dilution inputs.

Safe concentration range

VIP

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg VIP vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

Research Purposes Only

These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.

Reference Guide

Dosing Cycle

Peptide
VIP
Dosing
50-100 mcg per dose (up to 200 mcg in research protocols)
Dosing Frequency
1-2 times daily due to very short 2-minute half-life
Cycle Duration
As prescribed for specific condition
Storage
Lyophilized powder: 2-8°C refrigerated; Reconstituted: use immediately (very short stability, ~2 minute half-life)

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of VIP interactions with other common peptides and substances.

Healing

bpc

Longevity

BPC-157

COMPATIBLE

No known negative interactions; different mechanisms.

COMPATIBLE

Healing

ll3

Immunity

LL-37

COMPATIBLE

Both have anti-inflammatory properties.

COMPATIBLE

Side effects

Contraindications

Severe hypotension

VIPoma or related tumors

Pregnancy or breastfeeding

Severe cardiac conditions

Stop signs

Severe hypotension

Allergic reaction symptoms

Severe diarrhea

Cardiac arrhythmias

Bad signs

Discolored powderCloudy solutionParticulates visible
Was it helpful?Yes

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What benefits can peptides offer in research?

Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.

What are some exciting applications of peptides in modern science?

Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.

How do peptides influence health and wellness?

Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.

Where can I find the latest studies on peptide applications?

Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.

Are there any guidelines for using peptides in research?

Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.

What is the difference between peptides and proteins?

Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.

How should peptides be stored?

Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.

Can peptides be taken orally?

Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.

VIPResearch References

VIP is an extensively studied compound

4Research references

VIP

VIP is an extensively studied compound

VIP as New Drug for Treatment of Primary Pulmonary Hypertension

VIP inhalation showed striking efficacy with increased mixed venous oxygen saturation and exercise capacity.

n.d.

Therapeutic Potential of VIP and VPAC2 in Type 2 Diabetes

VIP promotes glucose-dependent insulin secretion via VPAC2, reducing hypoglycemia risk.

n.d.

Therapeutic Potential of VIP in Neurological Disorders

VIP and receptors are promising therapeutic targets for AD, PD, and autism spectrum disorders.

n.d.

VIP Structure and Function for Therapeutic Applications

Comprehensive review of VIP receptor signaling and therapeutic applications.

n.d.